new glp 1 drugs coming Novo, Lilly buoyed by fast-growing GLP-1 drug sales From 'companion foods' to 'Nature's
Description
The GLP-1 Analogues Market estimated size and share is projected to exceed USD 322.85 Billion by 2034, with a forecasted CAGR of 21.3% during the period.
A new era for weight loss
Rotate placement daily to keep skin happy
Vegan Friendly
A new GLP-1 oral medication from AstraZeneca, known as elecoglipron, lowered blood sugar levels and led to 10.5% weight loss in a phase 2b clinical trial.
